Phosphagenics

Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and nutraceutical products.

Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and the London Stock Exchange's Alternative Investment Market (PSG). Phosphagenics' ADR's (PPGNY) are traded on the OTCQX in the US.

	Phosphagenics' executive appointment 20 May 2008 Phosphagenics today announced the appointment of Fred Banti as Senior Vice President and Chief Business Officer. To view the release in full please click here.

	Phosphagenics completes A$9.1m Capital Raising 07 May 2008 Phosphagenics today announced that it has raised A$9.1 m via a placement of approximately 60.6 million fully paid ordinary shares to leading overseas and domestic institutions, and other sophisticated investors, at 15 cents per share. To view the release in full please click here.

Web Site Design & Business Hosting by Simple I.D.